3.065

1.13% -0.035

Mereo Biopharma Group Plc Adr (MREO)

Overview News Price History Option Chain Discussions Forecast

Mereo Biopharma Group Plc Adr stock is traded at $3.065, with a volume of 818.43K. It is down -1.13% in the last 24 hours and down -18.48% over the past month. Mereo BioPharma Group PLC is a United Kingdom (U.K.) based biopharmaceutical company focused on the development of innovative therapeutics for rare diseases. The Company has developed a portfolio of late-stage clinical product candidates, and its two rare disease product candidates are setrusumab for the treatment of osteogenesis imperfecta (OI) and alvelestat primarily for the treatment of severe alpha-1 antitrypsin deficiency-associated lung disease (AATD-LD).

Previous Close:

$3.10

Open:

$3.08

24h Volume:

818.43K

Relative Volume:

0.83

Market Cap:

$480.95M

Revenue:

$10.00M

Net Income/Loss:

$-29.47M

P/E Ratio:

-15.32

EPS:

-0.2

Net Cash Flow:

$-21.55M

1W Performance:

+1.83%

1M Performance:

-18.48%

6M Performance:

-16.26%

1Y Performance:

-20.80%

1-Day Range:

$3.025

$3.12

1-Week Range:

$2.85

$3.255

52-Week Range:

$2.525

$5.02

Mereo Biopharma Group Plc Adr Stock (MREO) Company Profile

Name

Mereo Biopharma Group Plc Adr

Sector

Healthcare (1187)

Industry

Biotechnology (679)

Phone

4403330237300

Address

ONE CAVENDISH PLACE, LONDON

Employee

Twitter

@MereoBioPharma

Next Earnings Date

2024-09-05

Latest SEC Filings

MREO's Discussions on Twitter

Compare MREO with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
MREO Mereo Biopharma Group Plc Adr	3.07	480.95M	10.00M	-29.47M	-21.55M	-0.20
VRTX Vertex Pharmaceuticals Inc	473.89	123.91B	10.63B	-479.80M	-1.35B	-1.99
REGN Regeneron Pharmaceuticals Inc	715.62	78.94B	14.20B	4.41B	3.54B	38.28
ARGX Argen X Se Adr	651.19	39.98B	1.86B	-40.29M	-1.28B	-0.85
ALNY Alnylam Pharmaceuticals Inc	274.97	35.89B	2.09B	-332.26M	16.06M	-2.62
BNTX Biontech Se Adr	118.44	28.75B	3.30B	-501.07M	1.03B	-2.1146

Mereo Biopharma Group Plc Adr Stock (MREO) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Dec-06-24	Initiated	Jefferies	Buy
Jun-13-24	Initiated	Robert W. Baird	Outperform
Oct-13-23	Resumed	BTIG Research	Buy
Aug-12-22	Initiated	Cantor Fitzgerald	Overweight
May-05-21	Initiated	BTIG Research	Buy
Apr-05-21	Initiated	Needham	Buy

View All

Mereo Biopharma Group Plc Adr Stock (MREO) Latest News

Feb 06, 2025

Prepare Yourself for Liftoff: Mereo Biopharma Group Plc ADR (MREO) - SETE News

Feb 06, 2025

There is no doubt that OrganiGram Holdings Inc (OGI) ticks all the boxes. - SETE News

Feb 06, 2025

Check Out ImmunoPrecise Antibodies Ltd (IPA)’s Trade Data Rather Than the Analysts’ Views - SETE News

Feb 06, 2025

Feb 04, 2025

Recent Insider Activity Could Benefit Mereo Biopharma Group Plc ADR (MREO) - Knox Daily

Feb 04, 2025

Analyzing Digital Turbine Inc (APPS) After Recent Trading Activity - Knox Daily

Feb 04, 2025

Market Insights: Mereo Biopharma Group Plc ADR (MREO)’s Notable Drop of -0.66, Closing at 2.99 - The Dwinnex

Feb 04, 2025

Daily Market Movement: Twist Bioscience Corp (TWST) Sees a 0.73 Increase, Closing at 52.75 - The Dwinnex

Feb 04, 2025

In the Green: Sensata Technologies Holding Plc (ST) Closes at 25.62, Up/Down -5.67 from Previous Day - The Dwinnex

Feb 04, 2025

How should investors view Anavex Life Sciences Corporation (AVXL)? - US Post News

Feb 04, 2025

Health In Tech Inc (HIT) is an excellent investment, but the stock is overvalued/undervalued right now - US Post News

Feb 04, 2025

Was there any good news for Mereo Biopharma Group Plc ADR (MREO) stock in the last session? - US Post News

Feb 04, 2025

It would be worthwhile to take a closer look at Therealreal Inc (REAL) - US Post News

Feb 04, 2025

Lemonade Inc (LMND) deserves deeper analysis - US Post News

Feb 04, 2025

Jan 15, 2025

symbol__ Stock Quote Price and Forecast - CNN

Jan 15, 2025

Jan 13, 2025

Analyze Mereo Biopharma Group Plc ADR (NASDAQ: MREO) Before Investing. - Stocks Register

Jan 13, 2025

Jan 12, 2025

Mereo BioPharma Provides Update on Lead Clinical Programs - GlobeNewswire Inc.

Jan 12, 2025

Mereo BioPharma's Setrusumab Advances Phase 3 Trial as Alvelestat Gains Key EU Support - StockTitan

Jan 12, 2025

Dec 17, 2024

How Are Things Looking For Mereo Biopharma Group Plc ADR (NASDAQ: MREO) For The Short Term? - Stocks Register

Dec 17, 2024

Dec 16, 2024

Crude Oil Down 1%; Webuy Global Shares Spike Higher - Benzinga

Dec 16, 2024

Dec 15, 2024

Mereo BioPharma's SWOT analysis: rare disease pipeline drives stock potential - Investing.com

Dec 15, 2024

Nov 25, 2024

Mereo BioPharma's SWOT analysis: rare disease stock poised for growth - Investing.com

Nov 25, 2024

Nov 01, 2024

European Equities Traded in the US as American Depositary Receipts Lower in Wednesday Trading - MSN

Nov 01, 2024

Oct 15, 2024

Do investors need to be concerned about Mereo Biopharma Group Plc ADR (MREO)? - US Post News

Oct 15, 2024

Oct 14, 2024